Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024 - Seite 3

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240401996705/en/

The Charles River Laboratories International Stock at the time of publication of the news with a raise of +0,84 % to 251,1EUR on Tradegate stock exchange (28. März 2024, 22:26 Uhr).